MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: Highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate

Ken‐ichi Yoshida(Daiichi Sankyo (Germany)), William J. Watkins, Hironobu Nitanai, Hiroko Kanda, Makoto Takemura, Yoshihiro Yokomizo, Ving J. Lee(Essential Research (United States)), Kiyoshi Nakayama, Noriko Kuru, Kenji Namba(Daiichi University of Pharmacy), Masami Ohtsuka, Yuichiro Imamura(Daiichi University of Pharmacy), Atsunobu Sakamoto, Jason Z. Zhang(Essential Research (United States)), Kazuki Hoshino, Kumi Yoshida(Aichi Institute of Technology)
Bioorganic & Medicinal Chemistry
August 23, 2007
Cited by 130


Related Papers